Medisepte - LIPO-XFAT
LIPO-Xᶠᵃᵗ
Phosphatidylcholine + Carnitine + Sodium Deoxycholate + Peptide
Advanced Fat-Reducing Formula for Body Contouring
Non-Invasive Treatment with an Active Slimming Complex
LIPO-XFAT is an innovative therapy designed for the reduction of localized adipose tissue and effective body contouring. It is based on a synergistic combination of phosphatidylcholine and sodium deoxycholate, providing a powerful lipolytic effect.
This action is further enhanced by a peptide complex that delivers an additional firming and tightening effect on tissues. The inclusion of L-Carnitine accelerates lipolysis and improves the metabolization of released fatty acids, enhancing both efficiency and results.
The broad-spectrum composition of LIPO-XFAT ensures a comprehensive body-shaping effect while maintaining the skin in excellent condition. LIPO-XFAT is a non-invasive body contouring treatment that promotes the breakdown of fat cells and triglycerides into glycerol and free fatty acids. These released fats are transported to the liver, where they are metabolized and naturally eliminated from the body.
Key Ingredients
Water
Phosphatidylcholine
Carnitine
Sodium Deoxycholate
Acetyl Hexapeptide-8
Benzyl Alcohol
1-2 Hexanediol
Indications
Body contouring and body shape improvement
Reduction of localized fat and cellulite
Improvement of skin tone and firmness
Alternative and/or complementary treatment to surgical liposuction
Treatment Protocol
4–8 treatment sessions
30-day intervals between sessions
Do not exceed 5 ml per 10 cm² area
Maximum 30 ml per treatment session
Contraindications
LIPO-XFAT should not be used:
Directly in areas of large blood vessels
In areas with non-absorbable implants
In patients with known hypersensitivity to any of the ingredients
In or around areas of inflammation or skin infection
In patients with bleeding disorders or those taking anticoagulants or thrombolytic agents
In patients with autoimmune skin diseases or severe allergies
In patients with liver or kidney diseases or dysfunction
In patients with diabetes or vascular disorders
In patients with porphyria
In patients with known epilepsy
During pregnancy and breastfeeding